Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M GELFAND

Showing results (681-690 of 889) with videos related to

Pageof 89
Sort By:
Journal of the American Academy of Dermatology|August 23, 2012
Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasisKatrina Abuabara, Joy Wan, Andrea B Troxel, et al.
Journal of the American Academy of Dermatology|August 23, 2011
Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patientsJoy Wan, Katrina Abuabara, Andrea B Troxel, et al.
Journal of the American Academy of Dermatology|February 1, 2017
Clinical and pathologic factors associated with subclinical spread of invasive melanomaThuzar M Shin, Waqas R Shaikh, Jeremy R Etzkorn, et al.
The Journal of Investigative Dermatology|December 21, 2018
Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Clinical Lymphoma & Myeloma|November 21, 2007
Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12Maria Wysocka, Sarah Newton, Bernice M Benoit, et al.
The British Journal of Dermatology|November 26, 2013
Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practiceK Callis Duffin, H Yeung, J Takeshita, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 21, 2018
Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional studyJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 10, 2018
Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Journal of Neurology|May 5, 2016
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT studyLisanne J Balk, Andrés Cruz-Herranz, Philipp Albrecht, et al.
Journal of the American Academy of Dermatology|January 12, 2017
Clinical factors associated with subclinical spread of in situ melanomaThuzar M Shin, Jeremy R Etzkorn, Joseph F Sobanko, et al.
Pageof 89

Showing results (681-690 of 889) with videos related to

Sort By:
Pageof 89
Journal of the American Academy of Dermatology|August 23, 2012
Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasisKatrina Abuabara, Joy Wan, Andrea B Troxel, et al.
Journal of the American Academy of Dermatology|August 23, 2011
Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patientsJoy Wan, Katrina Abuabara, Andrea B Troxel, et al.
Journal of the American Academy of Dermatology|February 1, 2017
Clinical and pathologic factors associated with subclinical spread of invasive melanomaThuzar M Shin, Waqas R Shaikh, Jeremy R Etzkorn, et al.
The Journal of Investigative Dermatology|December 21, 2018
Measurement Properties of the Hospital Anxiety and Depression Scale Used in Atopic Dermatitis in AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Clinical Lymphoma & Myeloma|November 21, 2007
Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12Maria Wysocka, Sarah Newton, Bernice M Benoit, et al.
The British Journal of Dermatology|November 26, 2013
Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practiceK Callis Duffin, H Yeung, J Takeshita, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 21, 2018
Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional studyJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 10, 2018
Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
Journal of Neurology|May 5, 2016
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT studyLisanne J Balk, Andrés Cruz-Herranz, Philipp Albrecht, et al.
Journal of the American Academy of Dermatology|January 12, 2017
Clinical factors associated with subclinical spread of in situ melanomaThuzar M Shin, Jeremy R Etzkorn, Joseph F Sobanko, et al.
Pageof 89